Oral News and Research

RSS

Study does not find causal association between assisted reproduction and ovarian cancer risk

Following concerns over many years that hormonal stimulation of the ovaries necessary for IVF may increase the risk of ovarian cancer, a nationwide cohort study from Denmark has now concluded that any perceived increase in risk is actually a statistical bias resulting from vigilant diagnosis at the time of treatment.

3 Jul 2018

U.S. researchers recommend development of anti-cancer drugs based on mechanism of Namodenoson

Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer, liver and inflammatory diseases, today announced that U.S. researchers published scientific findings recommending development of anti-Liver Cancer Drugs based on a mechanism of action utilized by Namodenoson.

2 Jul 2018

Study: Articulation-relevant brain regions are also active in perception of language

Brain regions that are involved in the articulation of language are also active in the perception of language.

2 Jul 2018

Antioxidant-enriched vitamin may decrease exacerbations in cystic fibrosis patients

An antioxidant-enriched vitamin may decrease respiratory exacerbations in people with cystic fibrosis(CF), according to new research published online in April in the American Journal of Respiratory and Critical Care Medicine.

2 Jul 2018

New medication may treat chemotherapy, radiotherapy-induced oral mucositis

Researchers from the University of Granada have developed new medication which could help to treat and prevent chemotherapy and radiotherapy-induced oral mucositis in head and neck cancer patients.

30 Jun 2018

Researchers focus on delivery of insulin in pill form

One mother vividly remembers her three-and-a-half-year-old son's pleas when he received insulin injections several times each day. "He would beg and plead, 'Don't do it Momma!'" she recalls.

29 Jun 2018

Review discusses complexity of immune-suppressive mechanisms in tumor milieu of cancers

Cancers control immune systems and evade immune detection using mediators consisting of immune checkpoint molecules and cellular systems associated with immune suppression.

29 Jun 2018

URI researchers working to develop novel medication to treat alcohol use disorder

Alcohol abuse is among the leading causes of preventable death in the United States, killing more than 88,000 people a year, according to the Centers for Disease Control.

28 Jun 2018

FDA approves cannabis based drug for severe form of epilepsy

The U.S. Food and Drug Administration (FDA) on the 25th of June 2018 approved Epidiolex oral solution that is essentially cannabidiol or the active component of marijuana or cannabis. As of now the drug is approved for use in two rare forms of epilepsy - Lennox-Gastaut syndrome and Dravet syndrome. The approval comes for individuals over two years of age.

28 Jun 2018

New approach needed to treat type 2 diabetes in youth

A major study has found that medicines used to treat diabetes in adults are not effective on youth. The researchers say the finding is disturbing because type 2 diabetes among youth is a growing problem.

27 Jun 2018

Researchers examine new influenza drug's mode of action in detail

The new influenza drug Xofluza, developed by the Japanese pharmaceutical company Shionogi, was approved for clinical use in Japan in February 2018.

26 Jun 2018

FDA approves new marijuana-based drug to treat rare and severe forms of epilepsy

The U.S. Food and Drug Administration today approved Epidiolex (cannabidiol) oral solution for the treatment of seizures associated with two rare and severe forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome, in patients two years of age and older.

25 Jun 2018

AntiCancer's oral drug overcomes gemcitabine resistance in mouse models of human pancreatic cancer

Pancreatic cancer is lethal in about 95% of cases mostly due to failure of first-line therapy gemcitabine. AntiCancer Inc.'s oral methioninase (AC 00619), which is in late pre-clinical development as an anti-cancer as well as an anti-aging drug, has now been shown to overcome gemcitabine resistance in mouse models of human pancreatic cancer, including AntiCancer's patient-derived orthotopic xenograft mouse models.

25 Jun 2018

Urgent steps needed to tackle low vitamin D intakes in UK South-Asians

Public health strategies are urgently required to tackle low intakes of vitamin D in the UK South-Asian population, finds a new study in the Journal Public Health Nutrition.

25 Jun 2018

Unique patch could revolutionize treatment of painful recurring ulcers

A plaster which sticks to the inside of your mouth is revolutionising the treatment of painful recurring ulcers.

25 Jun 2018

BetterYou’s new Magnesium Bone Lotion helps maximize bone health

Pioneering natural health company BetterYou has developed a scientifically magnesium chloride and calcium supplement for those who want to maximize their bone health conveniently and effectively.

From BetterYou Ltd 21 Jun 2018

New classification system for periodontal health, diseases and conditions announced at EuroPerio9 congress

A new global classification system for periodontal health, diseases and conditions, as well as peri-implant diseases and conditions, has been announced today at the EuroPerio9 congress, the world's leading congress in periodontology and implant dentistry.

21 Jun 2018

New study is testing safety and efficacy of glycoside in breaking up kidney stones

For anyone who has suffered from kidney stones, the painful condition is not easily treatable, and patients are typically prescribed strong pain medication and fluids to alleviate symptoms.

20 Jun 2018

Can-Fite provides update on Phase II clinical trial with drug candidate Namodenoson

Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer, liver and inflammatory diseases, today provided an update on its Phase II clinical trial with drug candidate Namodenoson in the treatment of advanced hepatocellular carcinoma in patients whose disease has progressed on sorafenib therapy.

19 Jun 2018

Study finds IV acetaminophen to be no more effective than oral counterpart for colectomy patients

Intravenous acetaminophen is no more effective than oral acetaminophen for patients undergoing colorectal procedures, Mount Sinai researchers report in a first-of-its-kind study.

19 Jun 2018

Oral News and Research

Study does not find causal association between assisted reproduction and ovarian cancer risk

U.S. researchers recommend development of anti-cancer drugs based on mechanism of Namodenoson

Study: Articulation-relevant brain regions are also active in perception of language

Antioxidant-enriched vitamin may decrease exacerbations in cystic fibrosis patients

New medication may treat chemotherapy, radiotherapy-induced oral mucositis

Researchers focus on delivery of insulin in pill form

Review discusses complexity of immune-suppressive mechanisms in tumor milieu of cancers

URI researchers working to develop novel medication to treat alcohol use disorder

FDA approves cannabis based drug for severe form of epilepsy

New approach needed to treat type 2 diabetes in youth

Researchers examine new influenza drug's mode of action in detail

FDA approves new marijuana-based drug to treat rare and severe forms of epilepsy

AntiCancer's oral drug overcomes gemcitabine resistance in mouse models of human pancreatic cancer

Urgent steps needed to tackle low vitamin D intakes in UK South-Asians

Unique patch could revolutionize treatment of painful recurring ulcers

BetterYou’s new Magnesium Bone Lotion helps maximize bone health

New classification system for periodontal health, diseases and conditions announced at EuroPerio9 congress

New study is testing safety and efficacy of glycoside in breaking up kidney stones

Can-Fite provides update on Phase II clinical trial with drug candidate Namodenoson

Study finds IV acetaminophen to be no more effective than oral counterpart for colectomy patients

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News